Skip to content

The Current State of heart failure with preserved ejection fraction in Japan: From Etiology to Treatment

The Current State of heart failure with preserved ejection fraction in Japan: From Etiology to Treatment - The Current State of Heart Failure with Preserved Ejection Fraction in Japan: From Etiology to Treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000033436
Enrollment
30000
Registered
2018-07-18
Start date
2017-08-14
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure

Interventions

None listed

Sponsors

Shonan Fujisawa Tokushukai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: all cases receiving first echocardiogram

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Events are described by all-cause death, hospitalization by cardiovascular disease, heart failure, and apoplexy, or receiving endovascular therapy (data from Diagnosis Procedure Combination database)

Countries

Japan

Contacts

Public ContactTakeshi Akasaka

Shonan Fujisawa Tokushukai Hospital Cardiology & Catheterization Laboratories

akasaka-cba@umin.ac.jp0466-35-1177

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026